In June 2024 (special issue), Gastroenterology published an entire issue (193 pages) focused on celiac disease. There was a lot of useful information on almost every aspect of this disease. Below I have summarized some of the points.
V Disepolo et al. Open Access! How Future Pharmacologic Therapies for Celiac Disease Will Complement the Gluten-Free Diet
- This article focuses on the emerging pharmacologic treatments



Related blog posts:
- Engineering New Treatments for Celiac Disease | gutsandgrowth
- Oral Treatment of Celiac Disease & Research Optimist | gutsandgrowth
G Malamut et al. Advances in Nonresponsive and Refractory Celiac Disease
- This article addresses nonresponsive CeD and refractory CeD. In the pediatric population, nonresponsive CeD is mainly related to persistent gluten exposure. Refractory CeD is rare in children.
- Related blog post: What To Do For Pediatric Patients with Non-Responsive Celiac Disease
